Post Hoc Subgroup Analysis of Clinical Outcomes in Patients With High‐Risk Metastatic Hormone‐Naïve Prostate Cancer: Results From a 3‐Year Interim Analysis of the J‐ROCK Study

Documenti analoghi

• Current Evidence on Cabazitaxel for Prostate Cancer Therapy: A Narrative Review
  di: Kazuhiro Suzuki, et al.
  Pubblicazione: (2025)
• Phase 3 Study of Talazoparib Plus Enzalutamide Versus Placebo Plus Enzalutamide as First‐Line Treatment in Patients With Metastatic Castration‐Resistant Prostate Cancer: TALAPRO ‐2 Japanese Subgroup Analysis
  di: Nobuaki Matsubara, et al.
  Pubblicazione: (2024)
• Reviewer's Comment on Skin Phototoxicity With Aminolevulinic Acid Hydrochloride in Patients With Non‐Muscle Invasive Bladder Cancer
  di: Hideyasu Matsuyama
  Pubblicazione: (2026)
• Comparative Effectiveness of First‐Line Treatments for Castration‐Resistant Prostate Cancer: A Large‐Scale Retrospective Study in Japan
  di: Akihito Hashizume, et al.
  Pubblicazione: (2025)
• A test of Amati relation using HII galaxy distances
  di: Okazaki, Rikiya, et al.
  Pubblicazione: (2025)